IGMS (IGM Biosciences Inc.) Bozor qiymatining balans qiymatiga nisbati
IGM Biosciences, Inc. (IGMS) global immunologiya sog'liqni saqlash giganti bilan hamkorlik orqali noyob antitelalarni ishlab chiqishni tezlashtirmoqda. Laboratoriya diversifikatsiyasi va maxsus sovuq zanjirli transport yuqori marjalarni ta'minlamoqda. Autoimmun patologiyalarni davolashga bo'lgan ulkan talab savdo bazasini shakllantiradi va ushbu grafikdagi kompaniyaning narxning buki nisbati buni aniq ko'rsatadi. 0.74 ko'rsatkichi joriy biznes bahosini tasdiqlaydi.
%3A%20Sof%20aktivlarga%20nisbatan%20bozor%20kapitallashuvi&width=1200&height=400&colorIndex=0&v=mvrk6wqv.ssk-7as46ww&start=20220704&end=20261028&filename=GURU_Markets_-_IGMS_-_IGM-Biosciences-Inc._-_Market-Capitalization-to-Net-Assets "IGMS IGM Biosciences Bozor kapitallashuvining balans qiymatiga nisbati (04.07.2022 - 24.08.2025) | 👁️GURU.Markets👁️")
IGM Biosciences, Inc. (IGMS) moliyaviy va bozor koʻrsatkichlari kesimi
- narx va narxlar bo'yicha konsensus prognoz:
- bozor kapitallashuvi bo'yicha ma'lumotlar:
- balans kapitallashuvi bo'yicha ma'lumotlar:
- qarz va likvidlik bo'yicha ma'lumotlar:
Qarzning xususiy kapitalga nisbati IGM Biosciences, Inc.|IGMS - Uzoq muddatli qarzning kapitalga koeffitsiyenti|Qisqa muddatli qarzning o'z kapitaliga nisbati igmbio.com|IGMS - Kompaniyaning umumiy qarzi|Balans kapitallashuviga qarzlar IGM Bio|IGMS - Kompaniyaning uzoq muddatli qarzlari|Kompaniyaning qisqa muddatli majburiyatlari IGM Biosciences
Kompaniyaning dastlabki tahlili:IGM Biosciences Inc. - IGMS
Ushbu koeffitsiyent biznesning sof aktiv qiymatidan yuqori bo'lgan bozor premiumi hajmini belgilaydi. U barcha aksiyalarning joriy qiymatining kompaniyaning kitob kapitaliga nisbati sifatida hisoblanadi. Bozor kapitalizatsiyasining kitob qiymatiga nisbatini tahlil qilish orqali investor kelajakdagi daromadlar bo'yicha bozor kutganlarini baholaydi. IGM Biosciences, Inc. (IGMS) uchun yuqori premium uning noyob IgM antitanachalar platformasiga egaligi bilan oqlanadi. Bunday texnologik ustunliklar bozorga kompaniyani uning joriy moddiy aktivlaridan ancha yuqori baholash imkonini beradi.
Asosiy raqobatchilar
argenx SE - Bozor qiymatining balans qiymatiga nisbati|BNTX (biontech.de) - Balans qiymatiga nisbatan bozor kapitallashuvi|Bozor qiymatining balans qiymatiga nisbati abivax.com ABVX|Sof aktivlarga nisbatan bozor kapitallashuvi ADMA Biologics Inc|Protagonist Therapeutics Inc (PTGX) - Bozor kapitallashuvining balans qiymatiga nisbati|Balans qiymatiga nisbatan bozor qiymati Immunovant Therapeutics (IMVT)|Bozor kapitallashuvining balans qiymatiga nisbati KNSA (Kiniksa Pharmaceuticals)|grifols.com - Bozor kapitallashuvining balans qiymatiga nisbati|Bozor qiymatining balans qiymatiga nisbati Adaptive Biotechnologies Corporation (ADPT)|CLDX: Balans qiymatiga nisbatan bozor qiymati|AUPH (Aurinia Pharma) - Bozor qiymatining balans qiymatiga nisbati|BioCryst Corp (BCRX) - Kapitallashuvning sof aktivlarga nisbati|VERA (Vera Therapeutics, Inc.) - Bozor kapitallashuvining balans qiymatiga nisbati|Bozor kapitallashuvining balans qiymatiga nisbati dianthustx.com (DNTH)|Pharvaris (PHVS) - Kapitallashuvning sof aktivlarga nisbati|Balans qiymatiga nisbatan bozor qiymati AbCellera Biologics (ABCL)|Bozor kapitallashuvining balans qiymatiga nisbati TRML|Precigen Corp - Balans qiymatiga nisbatan bozor kapitallashuvi|PHAR: Bozor qiymatining balans qiymatiga nisbati|NKTR: Kapitallashuvning sof aktivlarga nisbati|UPB (Upstream Bio) - Bozor qiymatining balans qiymatiga nisbati|Kapitallashuvning sof aktivlarga nisbati Zenas Bio|IMNM (Immunome Corp) - Kapitallashuvning sof aktivlarga nisbati|Bozor kapitallashuvining balans qiymatiga nisbati GOSS|Bozor qiymatining balans qiymatiga nisbati KalVista Pharmaceuticals KALV|Kapitallashuvning balans qiymatiga nisbati septerna.com (SEPN)|PVLA: Bozor kapitallashuvining balans qiymatiga nisbati|Bozor qiymatining balans qiymatiga koeffitsiyenti Savara Inc SVRA|Bozor kapitallashuvining balans qiymatiga nisbati RIGL (Rigel Pharmaceuticals Inc)|ANAB - Balans qiymatiga nisbatan bozor kapitallashuvi|Bozor kapitallashuvining balans qiymatiga nisbati ATXS (Astria Therapeutics)|ENGN (engene.com) - Bozor qiymatining xususiy kapitalga nisbati|Bozor qiymatining balans qiymatiga nisbati RAPT|Kapitallashuvning sof aktivlarga nisbati Aerovate (JBIO)|Aclaris (ACRS) - Kapitallashuvning sof aktivlarga nisbati|Balans qiymatiga nisbatan bozor qiymati Kyverna Therapeutics, Inc (KYTX)|Bozor kapitallashuvining balans qiymatiga nisbati Tiziana Life Sciences TLSA|Bozor qiymatining balans qiymatiga nisbati cabalettabio.com CABA|Bozor kapitallashuvining balans qiymatiga nisbati VTYX (Ventyx Biosciences, Inc.)|THTX: Balans qiymatiga nisbatan bozor kapitallashuvi|Bozor qiymatining balans qiymatiga nisbati AVTX|ELDN (Eledon Pharmaceuticals, Inc) - Bozor qiymatining balans qiymatiga koeffitsiyenti|AGEN: Bozor qiymatining balans qiymatiga nisbati|Balans qiymatiga nisbatan bozor kapitallashuvi climbbio.com|Bozor kapitallashuvining balans qiymatiga nisbati ZURA (Zura Bio)|Kapitallashuvning sof aktivlarga nisbati aTyr Pharma Inc (ATYR)|Bozor kapitallashuvining balans qiymatiga nisbati ADAG|Balans qiymatiga nisbatan bozor kapitallashuvi ImageneBio IMA|STTK (Shattuck Therapeutics) - Bozor kapitallashuvining balans qiymatiga nisbati|EQ: Bozor qiymatining balans qiymatiga koeffitsiyenti|Bozor qiymatining balans qiymatiga nisbati connectbiopharm.com|Immunic (IMUX) - Kapitallashuvning balans qiymatiga nisbati|Bozor kapitallashuvining balans qiymatiga nisbati ATRA|Kapitallashuvning sof aktivlarga nisbati InflaRx GmbH|X4 Pharmaceuticals - Bozor kapitallashuvining balans qiymatiga nisbati|Bozor qiymatining balans qiymatiga koeffitsiyenti ACET (adicetbio.com)|Bozor qiymatining balans qiymatiga nisbati CELU|INMB - Balans qiymatiga nisbatan bozor kapitallashuvi|Kapitallashuvning sof aktivlarga nisbati Barinthus Bio (BRNS)|KZR - Balans qiymatiga nisbatan bozor qiymati|SAB Biotherapeutics - Bozor kapitallashuvining balans qiymatiga nisbati|AKTX (akaritx.com) - Balans qiymatiga nisbatan bozor kapitallashuvi|Bozor qiymatining balans qiymatiga nisbati Enlivex Therapeutics Ltd (ENLV)|Kapitallashuvning balans qiymatiga nisbati Q32 Bio Corp|Bozor kapitallashuvining balans qiymatiga nisbati GOVX (GeoVax Labs Inc)|Kapitallashuvning sof aktivlarga nisbati Edesa Biotech Corp EDSA|Kapitallashuvning sof aktivlarga nisbati IBIO|Balans qiymatiga nisbatan bozor kapitallashuvi Carisma Therapeutics Inc CARM|Bozor kapitallashuvining balans qiymatiga nisbati XTLB (XTL Biopharmaceuticals Ltd.)|BOLT - Balans qiymatiga nisbatan bozor kapitallashuvi|Bozor kapitallashuvining balans qiymatiga nisbati HCWB (hcwbiologics.com)|APVO (Aptevo Therapeutics Inc.) - Bozor qiymatining xususiy kapitalga nisbati|Bozor qiymatining balans qiymatiga nisbati AIM|Kapitallashuvning sof aktivlarga nisbati ADTX|GRI (GRI Bio) - Bozor qiymatining balans qiymatiga nisbati|Balans qiymatiga nisbatan bozor kapitallashuvi XRTX (XORTX Therapeutics Inc)|ReShape Lifesciences (HIND) - Bozor qiymatining balans qiymatiga nisbati|Sof aktivlarga nisbatan bozor kapitallashuvi Revelation Biosciences Corp REVB|Bozor kapitallashuvining balans qiymatiga nisbati Indaptus Therapeutics (INDP)|SCNI - Balans qiymatiga nisbatan bozor qiymati|CALI: Bozor kapitallashuvining balans qiymatiga nisbati|AFMD (Affimed N.V.) - Bozor kapitallashuvining balans qiymatiga nisbati|ALLK - Bozor qiymatining balans qiymatiga nisbati|Balans qiymatiga nisbatan bozor qiymati HOOK|Bozor qiymatining balans qiymatiga nisbati ITOS (iTeos Therapeutics)|Kapitallashuvning sof aktivlarga nisbati oceanbiomedical.com (OCEA)|Bozor kapitallashuvining balans qiymatiga nisbati TCBP (TC BioPharm)|THRD - Bozor kapitallashuvining balans qiymatiga nisbati